Continued evasion of neutralizing antibody response by Omicron XBB.1.16

Continued evasion of neutralizing antibody response by Omicron XBB.1.16

Summary: The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to challenge the efficacy of vaccination efforts against coronavirus disease 2019 (COVID-19). The Omicron XBB lineage of SARS-CoV-2 has presented dramatic evasion of neutralizing antibodies stimulated by...

Full description

Bibliographic Details
Main Authors: Julia N. Faraone, Panke Qu, Yi-Min Zheng, Claire Carlin, Daniel Jones, Ashish R. Panchal, Linda J. Saif, Eugene M. Oltz, Richard J. Gumina, Shan-Lu Liu
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Cell Reports
Subjects:
CP: Immunology
CP: Microbiology|
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124723012056

Internet

http://www.sciencedirect.com/science/article/pii/S2211124723012056

Similar Items